Rhumbline Advisers Increases Stock Position in Avantor, Inc. (NYSE:AVTR)

Rhumbline Advisers raised its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 1.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,922,368 shares of the company's stock after purchasing an additional 33,692 shares during the quarter. Rhumbline Advisers owned approximately 0.28% of Avantor worth $40,504,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its holdings in Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after purchasing an additional 625 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after acquiring an additional 835 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock valued at $63,000 after acquiring an additional 1,074 shares during the period. CKW Financial Group boosted its stake in Avantor by 116.7% during the fourth quarter. CKW Financial Group now owns 5,200 shares of the company's stock worth $110,000 after acquiring an additional 2,800 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its holdings in shares of Avantor by 30.8% during the third quarter. First Horizon Advisors Inc. now owns 5,629 shares of the company's stock valued at $146,000 after buying an additional 1,326 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Trading Down 0.8 %

AVTR traded down $0.15 during trading hours on Thursday, reaching $17.54. 2,071,481 shares of the company's stock traded hands, compared to its average volume of 5,519,548. The firm has a 50-day moving average price of $21.16 and a 200 day moving average price of $23.05. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $11.94 billion, a PE ratio of 16.86, a PEG ratio of 1.56 and a beta of 1.28. Avantor, Inc. has a 52-week low of $17.14 and a 52-week high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter last year, the business earned $0.22 EPS. As a group, sell-side analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Royal Bank of Canada lowered their target price on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a report on Monday, February 10th. Raymond James restated an "outperform" rating and issued a $24.00 target price (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Robert W. Baird dropped their price target on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research note on Monday, October 28th. Stifel Nicolaus cut their target price on Avantor from $28.00 to $26.00 and set a "buy" rating for the company in a research note on Monday, February 10th. Finally, UBS Group restated a "neutral" rating and set a $25.00 price target (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Avantor has a consensus rating of "Moderate Buy" and a consensus price target of $25.92.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.